{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:39:22Z","timestamp":1761100762643},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.humimm.2004.12.004","type":"journal-article","created":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T04:16:30Z","timestamp":1106712990000},"page":"231-240","source":"Crossref","is-referenced-by-count":6,"title":["Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect"],"prefix":"10.1016","volume":"66","author":[{"given":"Yaron","family":"Ilan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meir","family":"Ohana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Gotsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elazar","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2004.12.004_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft versus host disease","volume":"324","author":"Ferrara","year":"1991","journal-title":"New Engl J Med"},{"key":"10.1016\/j.humimm.2004.12.004_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4615-6349-5_4","article-title":"Graft versus host disease","volume":"77","author":"Vogelsang","year":"1997","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.humimm.2004.12.004_bib3","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.91.23.10762","article-title":"Oral tolerance","volume":"91","author":"Weiner","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humimm.2004.12.004_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0167-5699(97)01053-0","article-title":"Oral tolerance","volume":"18","author":"Weiner","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.humimm.2004.12.004_bib5","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.4049\/jimmunol.162.10.6247","article-title":"Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis","volume":"162","author":"Benson","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2004.12.004_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-2249.2003.02167.x","article-title":"Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis","volume":"132","author":"Ding","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humimm.2004.12.004_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1572-0241.2000.01935.x","article-title":"Treatment of experimental colitis by oral tolerance induction","volume":"95","author":"Ilan","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humimm.2004.12.004_bib8","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.7680493","article-title":"Double blind pilot trial of oral tolerization with myelin antigen in multiple sclerosis","volume":"261","author":"Weiner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.humimm.2004.12.004_bib9","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.8378772","article-title":"Effects of oral administration of type II collagen on rheumatoid arthritis","volume":"261","author":"Trentham","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.humimm.2004.12.004_bib10","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1172\/JCI118919","article-title":"Oral insulin treatment suppresses virus-induced antigen-specific destruction of \u03b2 cells and prevents autoimmune diabetes in transgenic mice","volume":"98","author":"Von Herrath","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humimm.2004.12.004_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510310314","article-title":"Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice","volume":"31","author":"Nagler","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2004.12.004_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0008-8749(85)90086-3","article-title":"Chronic graft versus host disease as a model for scleroderma. Description of a model system","volume":"94","author":"Jaffe","year":"1985","journal-title":"Cell Immunol"},{"key":"10.1016\/j.humimm.2004.12.004_bib13","first-page":"139","article-title":"Liver T cell subsets and adhesion molecules in murine graft versus host disease","volume":"16","author":"Howell","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humimm.2004.12.004_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0008-8749(92)90176-P","article-title":"Supperesor function of liver mononuclear cells isolated during chronic graft versus host disease","volume":"140","author":"Howell","year":"1992","journal-title":"Cell Immunol"},{"key":"10.1016\/j.humimm.2004.12.004_bib15","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V95.11.3613","article-title":"Induction of oral tolerance in splenocyte recipients towards pre-transplant antigens ameliorates chronic graft versus host disease in a murine model","volume":"95","author":"Ilan","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2004.12.004_bib16","first-page":"53","article-title":"Bone marrow transplantation for patients with chronic myeloid leukaemia","volume":"1","author":"Apperley","year":"1986","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humimm.2004.12.004_bib17","series-title":"Manual of clinical laboratory immunology","first-page":"847","article-title":"Cellular typing","author":"Devender","year":"1986"},{"key":"10.1016\/j.humimm.2004.12.004_bib18","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/00007890-199405270-00013","article-title":"Prediction by a modified mixed lymphocyte reaction assay of graft versus host disease and graft rejection after allogeneic bone marrow transplantation","volume":"57","author":"Bishara","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2004.12.004_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/10428199309148199","article-title":"Graft-versus-leukemia reactions in clinical bone marrow transplantation","volume":"10","author":"Mehta","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humimm.2004.12.004_bib20","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus host disease in human recipients of allogeneic-marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"New Engl J Med"},{"key":"10.1016\/j.humimm.2004.12.004_bib21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","article-title":"Antileukemic effect of chronic graft-versus host disease","volume":"304","author":"Weiden","year":"1981","journal-title":"New Engl J Med"},{"key":"10.1016\/j.humimm.2004.12.004_bib22","first-page":"1379","article-title":"Allogeneic bone marrow transplantation for leukemia in Europe","volume":"i","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2004.12.004_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2004.12.004_bib24","first-page":"155","article-title":"The graft-versus-leukemia (GVL) phenomenon","volume":"6","author":"Slavin","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humimm.2004.12.004_bib25","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","article-title":"Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia","volume":"73","author":"Sullivan","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2004.12.004_bib26","series-title":"Progress in bone marrow transplantation","first-page":"219","article-title":"Graft-versus leukemia reactions","author":"Truiit","year":"1987"},{"key":"10.1016\/j.humimm.2004.12.004_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft versus leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2004.12.004_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00007890-198709000-00002","article-title":"T cell subsets and graft-versus host disease","volume":"44","author":"Korngold","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2004.12.004_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2249.2002.01857.x","article-title":"Differential graft-versus leukemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis","volume":"129","author":"Ohata","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humimm.2004.12.004_bib30","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood.V97.10.2923","article-title":"Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon \u03b3 production","volume":"97","author":"Baker","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2004.12.004_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/bbmt.2003.50027","article-title":"Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response","volume":"9","author":"Jones","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2004.12.004_bib32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1286-4579(01)01456-3","article-title":"Oral tolerance","volume":"3","author":"Weiner","year":"2001","journal-title":"Microbes Infection"},{"key":"10.1016\/j.humimm.2004.12.004_bib33","doi-asserted-by":"crossref","unstructured":"Safadi R, Israeli E, Papo O, Shibolet O, Melhem A, Bloch A, Rowe M, Alper R, Klein A, Hemmed N, Segol O, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y: Treatment of chronic HBV infection via oral immune regulation towards hepatitis B virus proteins. Am J Gastroenterol (in press 2003).","DOI":"10.1111\/j.1572-0241.2003.07700.x"},{"key":"10.1016\/j.humimm.2004.12.004_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0528.2002.017412.x","article-title":"The liver as a site of T-cell apoptosis","volume":"174","author":"Crispe","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.humimm.2004.12.004_bib35","first-page":"1695","article-title":"Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for the prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia","volume":"23","author":"Champlin","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.humimm.2004.12.004_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1083-8791(01)70017-1","article-title":"Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation","volume":"7","author":"Shimoni","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2004.12.004_bib37","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1182\/blood.V91.9.3315","article-title":"Interleukin-12 inhibits graft versus host disease through Fas mediated mechanism associated with alterations in T cell activation and expansion","volume":"91","author":"Dey","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2004.12.004_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2004.12.004_bib39","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.189.7.1073","article-title":"Bone marrow NK1.1\u2212 and NK1.1+ T cells reciprocally regulate acute graft versus host disease","volume":"189","author":"Zeng","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2004.12.004_bib40","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4049\/jimmunol.167.4.2087","article-title":"Predominance of NK1.1+TCR\u03b1\u03b2+ or DX5+ TCR\u03b1\u03b2+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease","volume":"167","author":"Lan","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2004.12.004_bib41","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.278.5343.1623","article-title":"Requirement for V\u03b114 NKT cells in IL-12-mediated rejection of tumors","volume":"278","author":"Cui","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.humimm.2004.12.004_bib42","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4049\/jimmunol.164.3.1463","article-title":"Liver CD4\u2212 CD8\u2212 NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro","volume":"164","author":"Pied","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2004.12.004_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.1997.00303.x","article-title":"TCR \u03b1 \u03b2+ CD4\u2212 CD8\u2212 T cells differentiate extrathymically in an lck-independent manner and participate in early response against Listeria monocytogenes infection through interferon-\u03b3 production","volume":"91","author":"Kadena","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2004.12.004_bib44","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.182.4.1163","article-title":"Selective reduction of T cells bearing invariant V \u03b1 24J \u03b1 Q antigen receptor in patients with systemic sclerosis","volume":"182","author":"Sumida","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2004.12.004_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/34419","article-title":"Extreme Th1 bias of invariant V\u03b124J\u03b1Q T cells in type 1 diabetes","volume":"391","author":"Wilson","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2004.12.004_bib46","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.4049\/jimmunol.164.9.4458","article-title":"Analysis of human V \u03b1 24+ CD4+ NKT cells activated \u03b1-glycosylceramide-pulsed monocyte-derived dendritic cells","volume":"164","author":"Takahashi","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2004.12.004_bib47","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.510290334","article-title":"Liver associated lymphocytes expressing NK1.1 are essential for oral tolerance induction in a murine model","volume":"27","author":"Trop","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2004.12.004_bib48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.189.7.1121","article-title":"The natural killer T (NKT) cell ligand \u03b1-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin-12 production by dendritic cells and IL-12 receptor expression on NKT cells","volume":"189","author":"Kitamura","year":"1999","journal-title":"J Exp Med"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885904006950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885904006950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T19:50:36Z","timestamp":1682970636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885904006950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0198885904006950"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2004.12.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}